WallStreetZenWallStreetZen

NASDAQ: CRNX
Crinetics Pharmaceuticals Inc Stock Ownership - Who owns Crinetics Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Crinetics Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Coelho Rogerio VivaldiDirector2026-07-023,000$40.00
$120.00kSell
Stephanie OkeyDirector2026-06-17608$36.22
$22.02kSell
Stephanie OkeyDirector2026-06-176,292$35.62
$224.12kSell
Jeff E. KnightChief Dev. Operating Officer2026-04-0885,163$40.10
$3.42MSell
Jeff E. KnightChief Dev. Operating Officer2026-04-089,624$20.02
$192.67kBuy
Jeff E. KnightChief Dev. Operating Officer2026-04-0849,474$23.98
$1.19MBuy
Jeff E. KnightChief Dev. Operating Officer2026-04-0819,336$19.64
$379.76kBuy
Richard Scott StruthersPresident CEO2026-03-1613,196$37.11
$489.70kSell
Stephen F. BetzChief Scientific Officer2026-03-166,371$37.11
$236.43kSell
Stephen F. BetzChief Scientific Officer2026-03-164,241$37.77
$160.18kSell

1 of 4

CRNX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRNX insiders and whales buy or sell their stock.

CRNX Shareholders

What type of owners hold Crinetics Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC14.95%15,759,799$1.32BInstitution
Blackrock Inc8.04%8,478,815$708.15MInstitution
Farallon Capital Management LLC7.91%8,338,098$696.40MInstitution
Wellington Management Group LLP7.74%8,157,204$681.29MInstitution
Perceptive Advisors LLC7.50%7,908,985$660.56MInsider
Driehaus Capital Management LLC6.07%6,395,922$534.19MInstitution
Price T Rowe Associates Inc5.08%5,355,496$447.29MInstitution
Vanguard Capital Management LLC4.43%4,673,935$390.37MInstitution
Vanguard Portfolio Management LLC4.40%4,638,511$387.41MInstitution
Janus Henderson Group PLC4.29%4,520,251$377.53MInstitution

1 of 3

CRNX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRNX90.33%9.67%Net SellingNet Selling
PTGX84.37%15.63%Net SellingNet Selling
IONS96.88%3.12%Net SellingNet Selling
PRAX69.37%30.63%Net SellingNet Buying
SYRE79.27%20.73%Net SellingNet Selling
View Top Biotech Stocks

Crinetics Pharmaceuticals Stock Ownership FAQ

Who owns Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals (NASDAQ: CRNX) is owned by 116.44% institutional shareholders, 12.47% Crinetics Pharmaceuticals insiders, and 0.00% retail investors. Perceptive Advisors LLC is the largest individual Crinetics Pharmaceuticals shareholder, owning 7.91M shares representing 7.50% of the company. Perceptive Advisors LLC's Crinetics Pharmaceuticals shares are currently valued at $660.56M.

If you're new to stock investing, here's how to buy Crinetics Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.